Fifth Third Bancorp
RMD icon

Fifth Third Bancorp’s ResMed RMD Stock Holding History

Fifth Third Bancorp’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.4M Buy
32,985
+23,194
+237% +$5.78M 0.01% 561
2025
Q4 		$2.36M Sell
9,791
-99
-1% -$25.3K 0.01% 433
2025
Q3 		$2.71M Sell
9,890
-80
-0.8% -$21.9K 0.01% 404
2025
Q2 		$2.57M Sell
9,970
-366
-4% -$87.3K 0.01% 418
2025
Q1 		$2.31M Sell
10,336
-6
-0.1% -$1.4K 0.01% 422
2024
Q4 		$2.37M Sell
10,342
-583
-5% -$140K 0.01% 425
2024
Q3 		$2.67M Buy
10,925
+94
+0.9% +$21K 0.01% 426
2024
Q2 		$2.07M Sell
10,831
-89
-0.8% -$18.1K 0.01% 448
2024
Q1 		$2.16M Sell
10,920
-19
-0.2% -$3.48K 0.01% 447
2023
Q4 		$1.88M Buy
10,939
+1,350
+14% +$207K 0.01% 464
2023
Q3 		$1.42M Buy
9,589
+3,238
+51% +$585K 0.01% 512
2023
Q2 		$1.39M Sell
6,351
-135
-2% -$30.1K 0.01% 516
2023
Q1 		$1.42M Sell
6,486
-959
-13% -$208K 0.01% 511
2022
Q4 		$1.55M Buy
7,445
+182
+3% +$40K 0.01% 483
2022
Q3 		$1.59M Sell
7,263
-129
-2% -$29.4K 0.01% 460
2022
Q2 		$1.55M Buy
7,392
+1,058
+17% +$225K 0.01% 471
2022
Q1 		$1.54M Buy
6,334
+103
+2% +$24.9K 0.01% 505
2021
Q4 		$1.62M Buy
6,231
+626
+11% +$162K 0.01% 506
2021
Q3 		$1.48M Buy
5,605
+504
+10% +$138K 0.01% 515
2021
Q2 		$1.26M Buy
5,101
+410
+9% +$86.2K 0.01% 548
2021
Q1 		$910K Sell
4,691
-203
-4% -$40.7K ﹤0.01% 580
2020
Q4 		$1.04M Buy
4,894
+67
+1% +$13.4K 0.01% 542
2020
Q3 		$827K Sell
4,827
-46,650
-91% -$8.61M ﹤0.01% 555
2020
Q2 		$9.88M Buy
51,477
+48,308
+1,524% +$7.9M 0.06% 227
2020
Q1 		$467K Buy
3,169
+159
+5% +$25.3K ﹤0.01% 608
2019
Q4 		$466K Buy
3,010
+115
+4% +$16.6K ﹤0.01% 662
2019
Q3 		$391K Sell
2,895
-26
-0.9% -$3.41K ﹤0.01% 706
2019
Q2 		$356K Buy
2,921
+12
+0.4% +$1.33K ﹤0.01% 737
2019
Q1 		$302K Buy
2,909
+133
+5% +$13.7K ﹤0.01% 762
2018
Q4 		$316K Sell
2,776
-381
-12% -$40.8K ﹤0.01% 737
2018
Q3 		$364K Buy
3,157
+154
+5% +$16.9K ﹤0.01% 753
2018
Q2 		$311K Sell
3,003
-985
-25% -$99.7K ﹤0.01% 781
2018
Q1 		$393K Buy
3,988
+3
+0.1% +$283 ﹤0.01% 727
2017
Q4 		$337K Buy
3,985
+17
+0.4% +$1.4K ﹤0.01% 754
2017
Q3 		$305K Buy
3,968
+10
+0.3% +$765 ﹤0.01% 772
2017
Q2 		$308K Sell
3,958
-128
-3% -$9.16K ﹤0.01% 799
2017
Q1 		$294K Hold
4,086
– – ﹤0.01% 812
2016
Q4 		$254K Sell
4,086
-104
-2% -$6.37K ﹤0.01% 856
2016
Q3 		$271K Sell
4,190
-85
-2% -$5.66K ﹤0.01% 844
2016
Q2 		$270K Sell
4,275
-900
-17% -$53.1K ﹤0.01% 849
2016
Q1 		$299K Sell
5,175
-302
-6% -$17.1K ﹤0.01% 820
2015
Q4 		$294K Sell
5,477
-101
-2% -$5.69K ﹤0.01% 857
2015
Q3 		$284K Sell
5,578
-269
-5% -$14.5K ﹤0.01% 882
2015
Q2 		$330K Sell
5,847
-2,027
-26% -$128K ﹤0.01% 859
2015
Q1 		$565K Buy
7,874
+384
+5% +$24.9K ﹤0.01% 729
2014
Q4 		$420K Hold
7,490
– – ﹤0.01% 772
2014
Q3 		$369K Sell
7,490
-300
-4% -$15.3K ﹤0.01% 798
2014
Q2 		$394K Buy
7,790
+300
+4% +$14.9K ﹤0.01% 801
2014
Q1 		$335K Buy
7,490
+1,600
+27% +$71.9K ﹤0.01% 805
2013
Q4 		$277K Sell
5,890
-5,627
-49% -$285K ﹤0.01% 846
2013
Q3 		$608K Sell
11,517
-2,074
-15% -$101K 0.01% 691
2013
Q2 		$613K Buy
+13,591
New +$645K 0.01% 683

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Fifth Third Bancorp's RMD Position: Q1 2026 in Review

Fifth Third Bancorp increased its ResMed (RMD) stake by 237% in Q1 2026, buying an estimated $5.78M and bringing the position to 32,985 shares worth $7.4M. The position accounts for 0.01% of the portfolio, ranked #561.

Fifth Third Bancorp first reported a position in RMD in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.88M in Q2 2020. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Fifth Third Bancorp held 32,985 shares of ResMed worth $7.4M as of Q1 2026.
  • Fifth Third Bancorp bought 23,194 ResMed shares in Q1 2026, an estimated $5.78M.
  • ResMed made up 0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #561 holding.
  • Fifth Third Bancorp first reported a position in ResMed in Q2 2013 and has held it in 52 quarters since.
  • Fifth Third Bancorp's ResMed position peaked at $9.88M in Q2 2020.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.